The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
- DOI
- 10.1007/s13311-020-00878-7
- Published
- 2020 Oct
- Container
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13311-020-00878-7,
title = {The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.},
author = {Abdallah MS and Mosalam EM and Zidan AA and Elattar KS and Zaki SA and Ramadan AN and Ebeid AM},
year = {2020},
journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
doi = {10.1007/s13311-020-00878-7},
url = {https://doi.org/10.1007/s13311-020-00878-7}
}RIS
TY - JOUR TI - The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial. AU - Abdallah MS AU - Mosalam EM AU - Zidan AA AU - Elattar KS AU - Zaki SA AU - Ramadan AN AU - Ebeid AM PY - 2020 JO - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics DO - 10.1007/s13311-020-00878-7 UR - https://doi.org/10.1007/s13311-020-00878-7 ER -
APA
MS, A., EM, M., AA, Z., KS, E., SA, Z., AN, R., & AM, E. (2020). The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1007/s13311-020-00878-7
Source records
- pubmed · retrieved 2026-09-25T13:27:25.007Z